Angeliq side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Angeliq (drospirenone; estradiol). Common side effects include alopecia among females and abdominal discomfort among males.
The phase IV clinical study is created by eHealthMe based on 589 reports from the FDA, and is updated regularly.
What is Angeliq?
Angeliq has active ingredients of drospirenone; estradiol. It is often used in menopause. eHealthMe is studying from 632 Angeliq users. Check the latest studies of Angeliq.
589 people who take Angeliq and have side effects are studied.
What are the common side effects of Angeliq, by gender? *
What are the common side effects of Angeliq, by age (0-1 to 60+)? *
What are the common side effects of Angeliq, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Angeliq?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on drospirenone; estradiol (the active ingredients of Angeliq) and Angeliq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Angeliq:
- Angeliq (632 reports)
All Angeliq side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Stroke and drugs of ingredients of atovaquone - 6 seconds ago
- Osphena and Urinary Tract Infection for Women aged 60+ - 8 seconds ago
- Osphena and Uti for Women aged 60+ - 9 seconds ago
- Osphena and Cystitis for Women aged 60+ - 9 seconds ago
- Folate Deficiency and drugs of ingredients of verapamil hydrochloride - 9 seconds ago
- Osphena and Bladder Infection for Women aged 60+ - 9 seconds ago
- Caduet and Rash Generalised for Women aged 60+ - 9 seconds ago
- Caduet and Rash for Women aged 60+ - 10 seconds ago
- Caduet and Skin Redness Or Inflammation for Women aged 60+ - 10 seconds ago
- Caduet and Skin Rash for Women aged 60+ - 10 seconds ago